The immunogenic cell death induced by radiation [12] would increase tumor-targeting of NHS-IL2, leading to an enhanced activation of tumor-specific cytotoxic T-lymphocytes (CTLs) and other immune effector cells via the low-toxicity formulation of IL-2. Here, IL2 is linked to neoplasm.